LA Cabotegavir & Rilpivirine During Pregnancy
Rilpivirine PK in HIV+ pregnant women
FIGURE 1. Rilpivirine median plasma concentrations over time. Nonpregnant reference exposure was determined from package insert.12 Error bars are standard error of the median.
Pregnancy Outcomes and Pharmacokinetics in Pregnant Women Living With HIV Exposed to Long-Acting Cabotegravir and Rilpivirine in Clinical Trials - ID Week 2021 Patel.
MATERNAL DOLUTEGRAVIR (DTG) USE, AND PREGNANCY AND BIRTH OUTCOMES: THE ANTIRETROVIRAL PREGNANCY REGISTRY (APR)
Long acting injectable cabotegravir: updated efficacy and safety results from HPTN 084
S Delany-Moretlwe et al.
on behalf of the HPTN 084 study team
View Older Articles
Back to Top